The United States market has shown robust performance with a 1.2% increase over the last week and a remarkable 32% rise in the past year, while earnings are projected to grow by 16% annually. In this thriving environment, identifying high growth tech stocks involves looking for companies that not only capitalize on current technological trends but also demonstrate strong potential for sustained earnings growth.
Name | Revenue Growth | Earnings Growth | Growth Rating |
---|---|---|---|
Super Micro Computer | 20.86% | 27.98% | ★★★★★★ |
Sarepta Therapeutics | 23.67% | 44.28% | ★★★★★★ |
TG Therapeutics | 28.39% | 43.54% | ★★★★★★ |
Ardelyx | 27.19% | 66.44% | ★★★★★★ |
Invivyd | 42.91% | 70.39% | ★★★★★★ |
Amicus Therapeutics | 20.32% | 62.45% | ★★★★★★ |
AsiaFIN Holdings | 60.53% | 81.55% | ★★★★★★ |
Seagen | 22.57% | 71.80% | ★★★★★★ |
Travere Therapeutics | 27.16% | 69.88% | ★★★★★★ |
ImmunoGen | 26.00% | 45.85% | ★★★★★★ |
Click here to see the full list of 253 stocks from our US High Growth Tech and AI Stocks screener.
Here we highlight a subset of our preferred stocks from the screener.
Simply Wall St Growth Rating: ★★★★★☆
Overview: Cinemark Holdings, Inc., along with its subsidiaries, operates in the motion picture exhibition industry and has a market capitalization of approximately $3.28 billion.
Operations: Cinemark Holdings generates revenue primarily from its U.S. operations, contributing $2.24 billion, while its international segment adds $596.80 million.
Cinemark Holdings, transitioning into profitability this year, shows a promising trajectory with an expected earnings growth of 28.1% annually, outpacing the U.S. market average of 15.9%. Despite a challenging comparison to the broader Entertainment industry's growth rate of 3.8%, Cinemark's strategic focus on enhancing customer experience and expanding its digital engagement platforms could bolster future revenue streams, which are projected to grow at 8.9% per year—slightly above the market forecast of 8.8%. Moreover, with a robust forecast Return on Equity of 41.6% in three years' time and positive free cash flow, Cinemark is positioning itself as a resilient contender in the evolving entertainment landscape despite recent dips in quarterly earnings and revenue figures reported in September and August conferences.
Assess Cinemark Holdings' past performance with our detailed historical performance reports.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Evolent Health, Inc., through its subsidiary Evolent Health LLC, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States with a market capitalization of approximately $3.01 billion.
Operations: Evolent Health, Inc. focuses on specialty care management in the U.S., generating revenue primarily from its Pharmacy Services segment, which contributes approximately $2.35 billion.
Evolent Health, amid a dynamic healthcare tech landscape, is navigating its growth trajectory with significant R&D investments and strategic mergers and acquisitions. With a 13.6% expected annual revenue increase outpacing the US market's 8.8%, and an ambitious leap toward profitability within three years, Evolent is reinforcing its market position. Recent earnings reflect this upward trend with a shift from a substantial net loss to posting modest profits, evidencing effective operational adjustments and potential resilience in its business model. Moreover, ongoing discussions for potential sales to private equity underscore investor confidence in its innovative approach to healthcare solutions.
Explore historical data to track Evolent Health's performance over time in our Past section.
Simply Wall St Growth Rating: ★★★★★☆
Overview: Pure Storage, Inc. provides data storage and management technologies, products, and services globally with a market capitalization of approximately $17.42 billion.
Operations: Pure Storage generates revenue primarily from its computer storage devices segment, totaling approximately $3.01 billion. The company operates in the data storage and management sector, offering technologies and services across various regions.
Pure Storage is capturing attention with its robust R&D investment strategy, allocating significant resources to innovation which is evident from its R&D expenses. This emphasis on development is crucial as it supports the company's 11.3% expected annual revenue growth, outpacing the broader US market average of 8.8%. Moreover, Pure Storage's earnings are projected to surge by 37.3% annually, showcasing a strong trajectory in profitability that aligns with technological advancements and market demands. Recent strategic alliances, like the one with Commvault aimed at enhancing cyber resilience under stringent EU regulations, underscore Pure Storage’s proactive approach in adapting to evolving tech landscapes and regulatory frameworks.
Learn about Pure Storage's historical performance.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include NYSE:CNK NYSE:EVH and NYSE:PSTG.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。